Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 3 of the last 4 fiscal years.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 18 % of short-term debt in 2025; threshold 65 %.
-
Busy address KBO
11 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
PHARMACIE DE LA DRÊVE from Seneffe, company number BE0421582883, closed financial year 2025 with a result of € -44,195 after tax. For that financial year PHARMACIE DE LA DRÊVE recorded a gross margin of € 287,815 and equity of € -120,957. Compared with financial year 2024, the result moved from € -64,782 to € -44,195. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 24, 2026.
€ -120,957
▼ € 44,195 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -44,195
▲ 32 % less loss than in 2024
Profit after tax over the fiscal year.
€ 135,255
▲ 62% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -139,557.
People and assets in 2025
2.7
▲ 0.4 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 218,519
▲ 22% vs 2024
€ 80,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 55,310
▼ 20% vs 2024
Of which on lease € 2,800.
Debts at end 2025
€ 625,141
▼ 10% vs 2024
€ 71,212 is repaid this year. At this pace the long-term loan is gone in ≈ 9 years.
€ 188,325
▲ 80% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 32,134
▲ 43% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -12,788 | € 50,045 | € 192,962 | € 287,815 | ▲ 49% |
| Profit after taxes | € -113,966 | € -65,175 | € -64,782 | € -44,195 | ▲ € 20,586 |
| Equity | € 53,195 | € -11,980 | € -76,761 | € -120,957 | ▼ € 44,195 |
| Total debts | € 968,601 | € 1,571,122 | € 1,769,196 | € 1,798,714 | ▲ 2% |
| Cash | € 424,481 | € 172,514 | € 83,628 | € 135,255 | ▲ 62% |
| Land & buildings | € 325,885 | € 325,576 | € 1,130,535 | € 1,089,443 | ▼ 4% |
| Retained profit | € 34,595 | € -30,580 | € -95,361 | € -139,557 | ▼ € 44,195 |
| Bank debt | € 297,124 | € 764,529 | € 695,336 | € 625,141 | ▼ 10% |
| Balance sheet total | € 1,090,319 | € 1,627,666 | € 1,757,532 | € 1,739,428 | ▼ 1% |
| Employees (FTE) | 0.8 | 0.8 | 2.3 | 2.7 | ▲ 0.4 |
Key figures of PHARMACIE DE LA DRÊVE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMACIE DE LA DRÊVE?
What happened at PHARMACIE DE LA DRÊVE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New establishment in Thuin. KBO
- New annual accounts for financial year 2025: loss of € 44,195. filed late Source: NBB ↗
- Devanthinic Pharma SRL became a director. NBB
- New establishment in Seneffe. KBO
- Start of the company according to the CBE. KBO
In short
From € 113,966 loss in 2022 to € 44,195 loss in 2025.
Paid € 24 in corporate taxes since 2022.
On average € 106,600 of value added per employee in 2025.
A new publication or filing at PHARMACIE DE LA DRÊVE? We notify you, reason included.
Follow PHARMACIE DE LA DRÊVEDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of DEVANTHINIC PHARMA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
PHARMACIE DE LA DRÊVEBehind PHARMACIE DE LA DRÊVE is Devanthinic Pharma SRL. The shares are held by DEVANTHINIC PHARMA (100%).
Directors
According to the 2025 annual accounts
Director · represented by Anne André
Also active at: PHARMACIE DE BOIS-D'HAINE, PHARMACIE DE BASCOUP, PHARMACIE SENEFFE CENTRE, Pharmacie LOISEAU, PHARMACIE ANNE ANDRE, MARIEC.C-PHARMA, PHARMACIE DE LA GRAND RUE, PHARMACIE DE LA VILLE BASSE +2 more
since 2017
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Rue des Canadiens 24
7180 Seneffe
Avenue Reine Astrid 292
7180 Seneffe
Active since 8 May 1981
Drève des Alliés(THN) 10
6530 Thuin
Active since 10 September 2026
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 11 companies are registered at this address.
All companies at this address →PHARMACIE DE BOIS-D'HAINE same network
€ 317,344 gross margin · 2025
PHARMACIE DE BASCOUP same network
€ 517,152 gross margin · 2025
PHARMACIE SENEFFE CENTRE same network
€ 576,922 gross margin · 2025
PHARMACIE ANNE ANDRE same network
€ 357,760 gross margin · 2025
DEVANTHINIC PHARMA same network
€ 1.3 million gross margin · 2025
+6 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0421.582.883
- VAT number
- BE 0421.582.883
- Registered office
- Rue des Canadiens 24, 7180 Seneffe
- Names & denominations
- PHARMACIE DE LA DRÊVE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 8 May 1981
- Peppol
- Active · Active since 29 Dec 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers
Verhuur en exploitatie van eigen of geleased residentieel onroerend goed, exclusief sociale woningen
Verhuur en exploitatie van eigen of geleased niet-residentieel onroerend goed, exclusief terreinen
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels